{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:51:58Z","timestamp":1788540718361,"version":"build-2803163510"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s11999-007-0092-4","type":"journal-article","created":{"date-parts":[[2008,2,9]],"date-time":"2008-02-09T07:41:41Z","timestamp":1202542901000},"page":"714-721","source":"Crossref","is-referenced-by-count":149,"title":["Potent Anticoagulants are Associated with a Higher All-Cause Mortality Rate After Hip and Knee Arthroplasty"],"prefix":"10.1097","volume":"466","author":[{"given":"Nigel E.","family":"Sharrock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Gonzalez Della Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Lyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo A.","family":"Salvati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R9-29-20210317","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2106\/00004623-200103000-00004","article-title":"Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group.","volume":"83","author":"Comp","year":"2001","journal-title":"J Bone Joint Surg Am"},{"key":"R10-29-20210317","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2106\/00004623-197456020-00005","article-title":"2,012 total hip arthroplasties: a study of postoperative course and early complications.","volume":"56","author":"Coventry","year":"1974","journal-title":"J Bone Joint Surg Am"},{"key":"R17-29-20210317","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2106\/00004623-199709000-00011","article-title":"Prevention of deep-vein thrombosis after total hip arthroplasty: comparison of warfarin and dalteparin.","volume":"79","author":"Francis","year":"1997","journal-title":"J Bone Joint Surg Am"},{"key":"R18-29-20210317","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2106\/00004623-200007000-00004","article-title":"A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.","volume":"82","author":"Freedman","year":"2000","journal-title":"J Bone Joint Surg Am"},{"key":"R22-29-20210317","doi-asserted-by":"crossref","first-page":"853","DOI":"10.7326\/0003-4819-132-11-200006060-00002","article-title":"Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement: a randomized, double-blind, placebo-controlled trial.","volume":"132","author":"Heit","year":"2000","journal-title":"Ann Intern Med"},{"key":"R24-29-20210317","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00003086-199201000-00007","article-title":"Intraoperative heparin thromboembolic prophylaxis in primary total hip arthroplasty: a prospective, randomized, controlled, clinical trial.","volume":"274","author":"Huo","year":"1992","journal-title":"Clin Orthop Relat Res"},{"key":"R25-29-20210317","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00003086-199204000-00023","article-title":"Intraoperative adjusted-dose heparin thromboembolic prophylaxis in primary total hip arthroplasty.","volume":"277","author":"Huo","year":"1992","journal-title":"Clin Orthop Relat Res"},{"key":"R27-29-20210317","first-page":"123","article-title":"Pulmonary embolism and its prophylaxis following the Charnley total hip replacement.","volume":"127","author":"Johnson","year":"1977","journal-title":"Clin Orthop Relat Res"},{"key":"R33-29-20210317","first-page":"128","article-title":"Prevention of thromboembolic disease after non-cemented hip arthroplasty: a multimodal approach.","volume":"68","author":"Leali","year":"2002","journal-title":"Acta Orthop Belg"},{"key":"R36-29-20210317","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2106\/00004623-199703000-00001","article-title":"The efficacy of prophylaxis with low-dose warfarin for prevention of pulmonary embolism following total hip arthroplasty.","volume":"79","author":"Lieberman","year":"1997","journal-title":"J Bone Joint Surg Am"},{"key":"R37-29-20210317","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-0037-1614410","article-title":"APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee: a prospective study.","volume":"81","author":"Lindahl","year":"1999","journal-title":"Thromb Haemost"},{"key":"R42-29-20210317","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0037-1614411","article-title":"Prevention of deep vein thrombosis after hip replacement: comparison between two low-molecular heparins, tinzaparin and enoxaparin.","volume":"81","author":"Planes","year":"1999","journal-title":"Thromb Haemost"},{"key":"R44-29-20210317","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1055\/s-0038-1647346","article-title":"A comparison of general anesthesia and regional anesthesia as a risk factor for deep vein thrombosis following total hip surgery: a critical review.","volume":"64","author":"Prins","year":"1990","journal-title":"Thromb Haemost"},{"key":"R48-29-20210317","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.2106\/00004623-200211000-00014","article-title":"Effect of mechanical compression on the prevalence of proximal deep venous thrombosis as assessed by magnetic resonance venography.","volume":"84","author":"Ryan","year":"2002","journal-title":"J Bone Joint Surg Am"},{"key":"R51-29-20210317","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2106\/00004623-200002000-00010","article-title":"Recent advances in venous thromboembolic prophylaxis during and after total hip replacement.","volume":"82","author":"Salvati","year":"2000","journal-title":"J Bone Joint Surg Am"},{"key":"R52-29-20210317","first-page":"381","article-title":"Current concepts on the pathogenesis, diagnosis and multimodal prophylaxis of thromboembolic disease after total hip arthroplasty.","volume":"54","author":"Salvati","year":"2003","journal-title":"Minerva Ortop Traumatol"},{"key":"R55-29-20210317","first-page":"16","article-title":"Thrombogenesis during total hip replacement.","volume":"319","author":"Sharrock","year":"1995","journal-title":"Clin Orthop Relat Res"},{"key":"R60-29-20210317","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.2106\/00004623-199808000-00009","article-title":"Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement: a prospective, randomized trial.","volume":"80","author":"Warwick","year":"1998","journal-title":"J Bone Joint Surg Am"}],"container-title":["Clinical Orthopaedics & Related Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003086-200803000-00029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T12:18:35Z","timestamp":1684239515000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003086-200803000-00029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1007\/s11999-007-0092-4","relation":{},"ISSN":["0009-921X"],"issn-type":[{"value":"0009-921X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}